Ertugliflozin bei Älteren so effektiv wie bei Jüngeren
Tài liệu tham khảo
Monteiro P, Bergenstal RM, Toural E et al. Efficacy und safety of empaglifozin in older patients in the EMPA-REG OUTCOME trial. Age Ageing. 2019;48(6):859-66
Cahn A, Mosenzon O, Wiviott SD, et al. Efficacy and safety of dapaglifozin in the elderly: analysis from the DECLARE-TIMI 58 study. Diabetes Care. 2019; 43:468-75
Cherney DZI, Zinman B, Inzucchi SE, et al. Effects of empaglifozin on the urinary albumin-to creatinine ratio in patients with type 2 Diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomized, Placebo-controlled trial. Lancet Diabetes Endocrinol. 2017;5:610-21